The National Pharmaceutical Pricing Authority (NPPA) has brought 20 more drugs under price control. These include drugs to cure liver diseases, hormone tablets, anti-rabies immunoglobulin, anti-Tuberculosis and blood thinners. The NPPA has revised prices of 26 drugs. Some of these are anti-cancer drugs, anti-inflammatory medicines and anaesthetics. Of these 26 drugs, the NPPA has revised the ceiling prices of 10 formulations after the Department of Pharmace-uticals (DoP) issued review orders after the previous NPPA orders were challenged. After the matter was examined by the DoP, the NPPA was asked to refix the prices of these drugs. These have been calculated